(Press-News.org) Boston - Numerous studies conducted by researchers at Dana-Farber Cancer Institute show promising results for patients with endometrial, lung, breast, prostate, and colorectal cancers. The results of these studies, along with dozens of others led by Dana-Farber faculty, will be presented at this year’s American Association for Cancer Research (AACR) Annual Meeting on April 5-10, 2024, in San Diego, Calif.
The institute’s leading experts and researchers will present findings across a spectrum of diseases, underscoring their dedication to driving innovation, improving patient outcomes, and changing lives everywhere.
Rebecca Porter, MD, PhD, a medical oncologist in the Gynecological Oncology Program of the Susan F. Smith Center for Women’s Cancers, will present “A phase 2, two-stage study of mirvetuximab soravtansine (IMGN853) in combination with pembrolizumab in patients with microsatellite stable (MSS) recurrent or persistent endometrial cancer” in Session Clinical Trials Plenary Session CT008 on Sunday, April 7, 2024, 7:30-7:45 p.m. ET/4:30-4:45 p.m. PT. Full press release available here.
Other notable research from Dana-Farber includes:
Blood test may identify patients with non-small cell lung cancer subtype who can benefit from combination therapy
Pasi A. Jänne, MD, PhD, senior vice president for Translational Medicine, will present an update to his practice-changing FLAURA2 clinical trial published last year, revealing that patients with non-small cell lung cancer (NSCLC) marked by a mutation in the EGFR gene fared significantly better when treated with the drug osimertinib plus platinum-based chemotherapy than with osimertinib alone. This follow-up analysis of trial data shows that patients whose blood tested positive prior to therapy for tumor cell DNA (ctDNA) with an EGFR mutation stood to gain the most from osimertinib plus chemotherapy. Patients who had EGFR-mutant ctDNA in their blood prior to therapy had a higher degree of clinical benefit when treated with osimertinib and platinum-based chemotherapy compared to those treated with osimertinib alone. Jänne will present “FLAURA2: exploratory analysis of baseline (BL) and on-treatment plasma EGFRm dynamics in patients (pts) with EGFRm advanced NSCLC treated with first-line (1L) osimertinib (osi) ± platinum-pemetrexed” in the Clinical Trials Plenary Session CT017 on Tuesday, April 9, 2024, 1:45-2:00 p.m. ET/10:45-11:00 a.m. PT.
Exercise program can improve heart function in cancer survivors
Cami Christopher, MPH, a research scientist in the Department of Medical Oncology, Population Sciences, will present findings suggesting that a moderate to vigorous aerobic and resistance exercise program can improve a key aspect of heart function in survivors of breast, prostate, and colorectal cancer. Cancer survivors are at increased risk of cardiovascular problems such as atherosclerosis, high blood pressure, and heart failure due to the damaging effects of some cancer therapies. In this study, 90 survivors of breast, prostate, or colorectal cancer who were overweight and had completed chemotherapy and/or radiation therapy received either a circuit, interval-based exercise program or standard post-treatment care. Investigators found that, over a four-month period, vascular function improved significantly in the exercise group compared to the standard-care group. Christopher will present “Effects of a circuit, interval-based exercise program on vascular function among cancer survivors” in the Clinical Research, Prevention/Early Detection/Interception, Survivorship Poster Session (Presentation 6290; Poster Board 1) on Tuesday, April 9, 2024, 4:30-8:00 p.m. ET/1:30-5:00 p.m. PT.
Study provides first large-scale look at genetic architecture of prostate cancer in Sub-Saharan Africa
Timothy Rebbeck, PhD, the Vincent L. Gregory Professor of Cancer Prevention, led the first large-scale genomic analysis of prostate cancer in sub-Saharan Africa which revealed that the genetic architecture of the disease – its basic underpinnings in abnormalities in DNA – is unique to Africa and varies across the continent. All lab work and participant accrual for the study were conducted on the continent, a landmark in the effort to build cancer research capacity in Africa. Researchers examined the evolutionary history of regions of the genome associated with prostate cancer, developed a new method of gauging prostate cancer risk, and inferred ancestry-related genetic architectures in 3,393 men with prostate cancer and 3,509 men without the disease in Ghana, Nigeria, Senegal, South Africa, and Uganda. They identified 15 abnormalities at three locations on the genome that were broadly linked to prostate cancer, including four that had not previously been identified. Rebbeck will present “Genetic architecture, evolutionary genomics, and genomic risk of prostate cancer in sub-Saharan Africa” in the Prevention/Early Detection/Interception, Population Sciences Poster Session (Presentation 774; Poster Board 1) on Sunday, April 7, 2024, 4:30-8:00 p.m. ET/1:30-5:00 p.m. PT.
A full list of Dana-Farber led research at AACR is available.
In addition, the AACR will recognize Rebbeck, Christopher D.M. Fletcher, MD, FRCPath, David S. Pellman, MD, and Gordon J. Freeman, PhD, with 2024 Scientific Achievement Awards during the Annual Meeting.
For all AACR-related media inquiries, contact Ellen Berlin, Senior Director, External Communications at ellen_berlin@dfci.harvard.edu or 617-750-8884. Follow the meeting live on X using the hashtag #AACR2024 and follow Dana-Farber News on X at @DanaFarberNews.
END
Endometrial, lung, and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2024
2024-04-05
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Novel ADC and immunotherapy combo shows promise in endometrial cancer subtype
2024-04-05
Boston - In a small, investigator-initiated phase 2 study by Dana-Farber Cancer Institute investigators, a novel combination of an antibody-drug conjugate and an immune checkpoint inhibitor showed notable activity in pre-treated patients with a difficult-to-treat form of endometrial cancer. In this study, tumors were reduced in six out of 16 patients treated with the combination, including one case in which the cancer disappeared.
The study tested mirvetuximab soravtansine and pembrolizumab in patients with folate receptor-α ...
Study: eDNA methods give a real-time look at coral reef health
2024-04-05
Woods Hole, Mass– The human gut is full of microbes. Some microbes can make people sick, while others are responsible for balancing gut health. But humans aren’t the only species who’s health depends on these microorganisms. Coral reef ecosystems rely on microorganisms to recycle organic matter and nutrients. These cells also help feed corals and other life reliant on reefs. Researchers from WHOI studied the microbes in coral reef water by examining eight reefs in the U.S. Virgin Islands over a period of seven years, which included periods of hurricane and coral ...
Ocean waves propel PFAS back to land
2024-04-05
A new study by researchers at the Department of Environmental Science, Stockholm University, published in Science Advances, reveals that PFAS re-emit into the air from crashing ocean waves at levels comparable to or greater than other sources, establishing a cyclical transport process for these "forever chemicals" between land and sea.
“The common belief is that per- and polyfluoroalkyl substances, PFAS, drain from the land into the oceans where they stay to be diluted into the deep oceans ...
First atlas of the human ovary with cell-level resolution is a step toward artificial ovary
2024-04-05
Images
A new "atlas" of the human ovary provides insights that could lead to treatments restoring ovarian hormone production and the ability to have biologically related children, according to University of Michigan engineers.
This deeper understanding of the ovary means researchers could potentially create artificial ovaries in the lab using tissues that were stored and frozen before exposure to toxic medical treatments such as chemotherapy and radiation. Currently, surgeons can implant previously frozen ovarian tissue to temporarily restore hormone and egg production. However, this ...
Chemical reactions can scramble quantum information as well as black holes
2024-04-05
HOUSTON – (April 5, 2024) – If you were to throw a message in a bottle into a black hole, all of the information in it, down to the quantum level, would become completely scrambled. Because in black holes this scrambling happens as quickly and thoroughly as quantum mechanics allows. They are generally considered nature’s ultimate information scramblers.
New research from Rice University theorist Peter Wolynes and collaborators at the University of Illinois Urbana-Champaign, however, has shown that molecules can be as formidable at scrambling quantum information ...
With VECSELs towards the quantum internet
2024-04-05
The expansion of fiber optics is progressing worldwide, which not only increases the bandwidth of conventional Internet connections, but also brings closer the realization of a global quantum Internet. The quantum internet can help to fully exploit the potential of certain technologies. These include much more powerful quantum computing through the linking of quantum processors and registers, more secure communication through quantum key distribution or more precise time measurements through the synchronization of atomic clocks.
However, the differences between the glass fiber standard of 1550 nm and the system wavelengths of the various quantum bits ...
Two sex pheromone receptors for sexual communication in the American cockroach
2024-04-05
Sex pheromones are vital in facilitating the chemical communication that underpins insect courtship and mating behavior. Among female American cockroaches (Periplaneta americana), two key volatile sex pheromone components, periplanone-A (PA) and periplanone-B (PB), are predominantly released. Previous studies have indicated that PB is the primary component, but the precise interplay between PA and PB, alongside their regulatory mechanisms in male courtship and mating behavior has remained ambiguous.
Recently, a team led by Professor Sheng Li from the Institute of Insect Science and Technology, School of Life Sciences, South China Normal ...
WVU spearheading regional USDA project to increase agricultural production
2024-04-05
West Virginia University is leading one of 50 projects as part of a nationwide effort to increase farmland availability to underserved populations, while also helping producers obtain working capital and means of food distribution.
The WVU Institute for Community and Rural Health was awarded a five-year, $8.5 million cooperative agreement grant for the U.S. Department of Agriculture’s Increasing Land Access Program, funded by President Joe Biden’s Inflation Reduction Act.
Titled “Working Lands of Central Appalachia,” ...
UM Researcher writes about a key issue for the US 2024 elections: Air pollution exposures ought to be of significant interest for US voters
2024-04-05
MISSOULA – An opinion paper published by University of Montana professor Lilian Calderón-Garcidueñas MD, PhD identifies air pollution risk exposures and the development of Alzheimer’s and Parkinson’s diseases, frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS) in exposed populations.
Calderón-Garcidueñas coauthors, Dr. Alberto Ayala and Dr. Partha Mukherjee discussed US citizens are not fully aware of the harmful brain impact of exposures to ubiquitous anthropogenic combustion emissions and friction-derived nanoparticles, industrial nanoplastics, wildfires and ...
Electronic medical record tool helps clinicians diagnose mpox
2024-04-05
Diagnosing infectious conditions can be challenging. Diagnosis is especially challenging for uncommon and emerging infectious diseases for which there’s limited clinical experience. Nevertheless, successfully identifying patients with infectious diseases, especially communicable ones, is critical, so patients can be isolated to reduce disease spread.
To address this challenge, investigators from Massachusetts General Hospital, a founding member of the Mass General Brigham healthcare system, recently developed and validated a computer program that can be incorporated into electronic medical record systems to help clinicians diagnose mpox (formerly known as monkeypox).
The research ...